EGFR and lung adenocarcinoma: In lung adenocarcinoma studies in the Chinese population, carriers of the rs1897990‐T allele had a significantly increased risk (OR = 1.32, 95% CI: 1.08–1.60), possibly related to aberrant activation of EGFR signalling driven by EGF overexpression in the tumor microenvironment [10].